A
Atul Gupta
Researcher at University of Cambridge
Publications - 121
Citations - 3560
Atul Gupta is an academic researcher from University of Cambridge. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 24, co-authored 109 publications receiving 2461 citations. Previous affiliations of Atul Gupta include Imperial College London & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
Davies Adeloye,Omer Elneima,Luke Daines,Krisnah Poinasamy,Jennifer K Quint,Samantha Walker,Christopher E. Brightling,Salman Siddiqui,John R. Hurst,James D. Chalmers,Paul E Pfeffer,P. Novotny,Thomas M Drake,Liam G Heaney,Igor Rudan,Aziz Sheikh,Anthony De Soyza,Mohammad Abdollahi,Dhiraj Agarwal,Riyad Al-Lehebi,Peter J. Barnes,Jagadeesh Bayry,Marcel Bonay,Louis Bont,Arnaud Bourdin,Tom Brown,Gaetano Caramori,Amy Hai Yan Chan,David H. Dockrell,S. Doe,Jamie Duckers,Anthony D'Urzo,Magnus Ekström,Cristóbal Esteban,Catherine M. Greene,Atul Gupta,Jennifer L Ingram,Ee Ming Khoo,Fanny W.S. Ko,Gerard H. Koppelman,Brian J. Lipworth,Karin Lisspers,Michael R. Loebinger,José Luis López-Campos,Matthew Maddocks,David M. Mannino,Miguel Ángel Martínez-García,Renae J McNamara,Marc Miravitlles,Pisirai Ndarukwa,Alison Pooler,Chin Kook Rhee,Peter Schwarz,Dominick E. Shaw,Michael C Steiner,Andrew Tai,Charlotte Suppli Ulrik,Paul Walker,Michelle C. Williams +58 more
TL;DR: In this article, a consensus exercise was conducted to identify research priorities with the aim of understanding the long-term effects of acute COVID-19, with a focus on people with pre-existing airway disease and the occurrence of new-onset airways disease and associated symptoms.
Journal ArticleDOI
Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach
Cara Bossley,Louise Fleming,Nicola Ullmann,Atul Gupta,Alexandra Adams,Prasad Nagakumar,Andrew Bush,Sejal Saglani +7 more
TL;DR: A multidomain evaluation of systemic steroid responsiveness using pragmatic clinical assessments confirms childhood STRA is heterogeneous and that a complete response in symptoms and inflammatory and physiologic parameters is rare.
Journal ArticleDOI
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype
Atul Gupta,Masanori Ikeda,Bob Geng,Jay Azmi,Robert Price,Eric S. Bradford,Steven W. Yancey,Jonathan Steinfeld +7 more
TL;DR: The long-term safety, pharmacodynamic and efficacy data from this study support a positive benefit-risk profile for mepolizumab in children with severe asthma with an eosinophilic phenotype and were similar to data in studies in adults and adolescents.
Journal ArticleDOI
Genetic testing in children with surfactant dysfunction
TL;DR: The UK experience in genetic diagnoses of surfactant protein dysfunction disorders is presented and a referral algorithm for neonates and children with persistent respiratory problems is developed to develop a validated algorithm for genetic evaluation with a need for international networking.
Journal ArticleDOI
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma.
Atul Gupta,Isabelle Pouliquen,Daren Austin,Robert G. Price,Rodger Kempsford,Jonathan Steinfeld,Eric S. Bradford,Steven W. Yancey +7 more
TL;DR: The pharmacokinetics and pharmacodynamics of mepolizumab following subcutaneous (SC) administration in children 6 to 11 years of‐age with severe eosinophilic asthma are characterized.